sb 203580 has been researched along with myricetin in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (myricetin) | Trials (myricetin) | Recent Studies (post-2010) (myricetin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 998 | 2 | 692 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, JK; Chien, TT; Hsu, YL; Kuo, PL; Tsai, CH | 1 |
Büsselberg, D; Hagenacker, T; Hillebrand, I; Schäfers, M | 1 |
2 other study(ies) available for sb 203580 and myricetin
Article | Year |
---|---|
Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.
Topics: Alkaline Phosphatase; Autoantigens; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Carrier Proteins; Cell Differentiation; Cell Line; Cell Line, Tumor; Collagen Type I; Cycloheximide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flavonoids; Humans; Imidazoles; Osteoblasts; Osteocalcin; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Pyridines; Ribonucleoproteins, Small Nuclear; Signal Transduction; Smad5 Protein; Smad8 Protein; snRNP Core Proteins; Time Factors; Transforming Growth Factor beta | 2007 |
Myricetin reduces voltage activated potassium channel currents in DRG neurons by a p38 dependent mechanism.
Topics: Animals; Enzyme Inhibitors; Flavonoids; Ganglia, Spinal; Imidazoles; Ion Channel Gating; Neurons; p38 Mitogen-Activated Protein Kinases; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Wistar | 2010 |